Last viewed: NVO


Prices are updated after-hours



nyse:NVO Novo Nordisk A/S

NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-7.1% 1m) (-27.3% 1y) (0.0% 2d) (-0.4% 3d) (-1.6% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 427,776,489,840

http://www.novonordisk.com
Sec Filling | Patents | 43258 employees


Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

obesity   diabetes   haemophilia   insulin   diabetic   hormone   growth hormone  

add to watch list Paper trade email alert is off

Press-releases


Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.27% H: 0.0% C: 0.0%

vent-02 trial therapeutics results
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.04% H: 0.19% C: -1.52%


Novo Nordisk A/S - share repurchase programme
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.04% H: 0.19% C: -1.52%

repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-08 (Crawled : 13:30) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.62% H: 0.5% C: 0.36%

repurchase
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-08 (Crawled : 12:30) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.62% H: 0.5% C: 0.36%

conference therapeutics
REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published: 2024-04-04 (Crawled : 06:00) - prnewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.1% H: 0.46% C: -2.32%

business natural million food
2023 Novo Holdings Asia Investments Annual Review/Business Update
Published: 2024-04-03 (Crawled : 07:00) - prnewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.75% H: 0.0% C: 0.0%

investments update asia
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.96% H: 1.3% C: 1.13%

repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 0.97% C: 0.04%

repurchase
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Published: 2024-03-25 (Crawled : 10:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 0.97% C: 0.04%

disease pipeline pharmaceuticals acquire cardiovascular
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K twitter stocktwits trandingview |
Technology Services
| 00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M twitter stocktwits trandingview |
Finance
| 22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K twitter stocktwits trandingview |
Retail Trade
| 22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K twitter stocktwits trandingview |
Energy Minerals
| 21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M twitter stocktwits trandingview |
Health Technology
| 16:30
RMCF | $3.51 -3.7% -3.85% 3.8K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar